Connor Willis

Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite U.S. study

M. Schabath, J. Villano, H. Bauer, 2022, Oncotarget.

Applying diagnosis support systems in electronic health records to identify wild-type transthyretin amyloid cardiomyopathy risk.

Kensaku Kawamoto, K. Nolen, T. Kannampallil, 2022, Future cardiology.

Cancer incidence in immunocompromised patients: a single-center cohort study

Kibum Kim, D. Brixner, D. Stenehjem, 2023, BMC Cancer.

Clinical and economic analysis of patients with acute myeloid leukemia by FLT3 status and midostaurin use at a Comprehensive Cancer Center.

D. Brixner, T. Kovacsovics, D. Stenehjem, 2019, Leukemia research.

Tumor mutational burden in lung cancer: a systematic literature review

Michelle Fiander, D. Brixner, D. Stenehjem, 2019, Oncotarget.

Patient Perspectives on the Use of Digital Technology to Help Manage Cystic Fibrosis

J. Biskupiak, Dave Young, D. Brixner, 2022, Pulmonary medicine.

Caregiver burden by treatment and clinical characteristics of patients with glioblastoma

Jennie W. Taylor, C. Ulrich, H. Colman, 2021, Supportive Care in Cancer.

SCREENING OF PATIENTS AT RISK FOR WILD TYPE ATTR-CM USING A COMPUTATIONAL MACHINE LEARNING ALGORITHM

Kensaku Kawamoto, J. Biskupiak, J. Nativi-Nicolau, 2021, Journal of the American College of Cardiology.

Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study.

Jennie W. Taylor, H. Colman, A. Chakravarti, 2023, Future oncology.